Home » Medistem, Cytori Sign Licensing Deal for U.S. Patent
Medistem, Cytori Sign Licensing Deal for U.S. Patent
Medistem and Cytori have signed a deal in which Cytori will obtain rights to Medistem’s patent on ADRC, used to treat autoimmune diseases.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May